SCI Abstract

search
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
Impulsivity induced by dopaminergic agents, like pramipexole and aripiprazole, can lead to behavioral addictions that impa...
Emergency Department Use of Heart Failure-Exacerbating Medications in Patients with Chronic Heart Failure
Emergency Department Use of Heart Failure-Exacerbating Medications in Patients with Chronic Heart Failure
Use of heart failure-exacerbating medications (HFEMs) may lead to preventable episodes of acute decompensated heart failur...
Paracetamol Dosing Errors in People Aged 12 Years and Over: An Analysis of Over 14,000 Cases Reported to an Australian Poisons Information Centre
Paracetamol Dosing Errors in People Aged 12 Years and Over: An Analysis of Over 14,000 Cases Reported to an Australian Poisons Information Centre
Paracetamol dosing errors can cause acute liver injury, with potentially toxic doses only slightly above the therapeutic r...
Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations
Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations
Missing data and unmeasured confounding are key challenges for external comparator studies. This work evaluates bias and o...
A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review
A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review
The safety of antiviral agents in real-world clinical settings is crucial, as pre-marketing studies often do not capture a...
Adverse Drug Events in Ambulatory Care: A Cross-Sectional Study
Adverse Drug Events in Ambulatory Care: A Cross-Sectional Study
Adverse drug events (ADEs) are understudied in the ambulatory care setting. We aim to estimate the prevalence and characte...
Prenatal Exposure to Proton Pump Inhibitors and Risk of Serious Infections in Offspring During the First Year of Life: A Nationwide Cohort Study
Prenatal Exposure to Proton Pump Inhibitors and Risk of Serious Infections in Offspring During the First Year of Life: A Nationwide Cohort Study
Proton pump inhibitor (PPI) use in children increases the risk of infections, prompting inquiry into the impact of prenata...
Trends in Proton Pump Inhibitor Use in Sweden by Sex and Age: A Drug Utilisation Study
Trends in Proton Pump Inhibitor Use in Sweden by Sex and Age: A Drug Utilisation Study
Proton pump inhibitors (PPIs) are among the most popular drugs worldwide. Yet, there are concerns on long-term safety and ...
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health
The Global Use of Medicines [Internet]. 2023. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/...
Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied Worldwide
Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied Worldwide
The use of herbal products globally is substantial, but varying definitions and regulatory frameworks have led to differen...
Disproportionality Analysis and Characterisation of Medication Errors in EudraVigilance: Exploring Findings on Sexes and Age Groups
Disproportionality Analysis and Characterisation of Medication Errors in EudraVigilance: Exploring Findings on Sexes and Age Groups
While medication errors (MEs) have been studied in the European Medicines Agency’s EudraVigilance, extensive charact...
Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs
Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs
The incidence of drug-induced liver injury (DILI) is not known for most prescription medications. We aimed to estimate the...
An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury
An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury
The recent rise in acute kidney injury (AKI) incidence, with approximately 30% attributed to potentially preventable adver...
Safeguarding Patients in the AI Era: Ethics at the Forefront of Pharmacovigilance
Safeguarding Patients in the AI Era: Ethics at the Forefront of Pharmacovigilance
Artificial intelligence is increasingly being used in pharmacovigilance. However, the use of artificial intelligence in ph...
Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review
Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review
Pharmacovigilance (PV), or the ongoing safety monitoring after a medication has been licensed, plays a crucial role in pre...
Real-World Effectiveness and Safety of Tixagevimab–Cilgavimab: A Target Trial Emulation Study
Real-World Effectiveness and Safety of Tixagevimab–Cilgavimab: A Target Trial Emulation Study
Immunocompromised individuals are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection a...
Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis
Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis
Pregnant persons are susceptible to significant complications following COVID-19, even death. However, worldwide COVID-19 ...
The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System
The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System
This article reflects on the 2010 pharmacovigilance legislation of the European Union (EU). Its legislative aim of better ...
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports
Upadacitinib is indicated for diseases affecting persons of childbearing potential including rheumatoid arthritis, psoriat...
Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults
Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults
As the population ages, understanding the potential risks associated with inappropriate medication use becomes increasingl...
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is gaining attention in pharmacovigilance, but its ...
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry
Available data regarding the safety and efficacy of sotrovimab in pregnant patients remain limited due to their exclusion ...